WHO and CDC: Preparing for the Next Pandemic

Changes to guidance from the WHO and CDC should strengthen preparedness and response to future potential pandemic diseases.

Maximizing Pediatric Readiness in Emergency Departments

Emergency departments will need specialized equipment and staff to ensure pediatric readiness for improved survival.

Update on MRSA and MSSA

MRSA and MSSA continue to challenge the industry as resistant strains grow.

Unboxing Boxed Warnings and Risk Assessment for IG Products

FDA-mandated boxed warnings highlighting potential risks and clinicians performing comprehensive risk evaluations can help prevent the infrequent adverse drug reactions with IG products.

Using Synthetic Biology to Create Therapeutic Solutions

This revolutionary technology shows promise for addressing a myriad of challenges in medicine, but ethical dilemmas remain.

SARS-CoV-2 and COVID-19: Plasma Supply and IG Replacement Therapy to Protect Immunodeficient Patients

Can anti-SARS-CoV-2 antibodies in the plasma supply protect against COVID infection in
immunodeficient patients? Research suggests otherwise.

Plasma’s Pivotal Role in Cancer Therapy

Known as liquid gold, human plasma is proving to be a valuable ally in the fight against cancer.

Myths & Facts: Heart Disease (2026)

Heart disease is the leading cause of death in the U.S., so understanding its causes, diagnosis and treatment is imperative.

Complement Inhibitors as Therapeutic Agents for Autoimmune Disease

While still in their early stages of research, FDA has approved more than a dozen complement inhibitors to treat various conditions, and there is hope that more will be on the horizon to treat others.

Virtual Hospitals: A New Era of Care

Virtual hospitals bring hospital-level care directly to patients’ homes, representing a transformative step in healthcare delivery.